Cybin Inc.
5600-100 King Street West
Toronto, ON M5X 1C9


Doug Drysdale


Alex Nivorozhkin, Ph.D.

Chief Scientific Officer

Michael Palfreyman, Ph.D.

Chief R&D Officer

Alex Belser, Ph.D.

Chief Clinical Officer

John Kanaskis

Co-Founder & Chief Business Officer

Eric So

Co-Founder & President

Brett Greene

Chief Innovations Officer

Paul Glavine

Co-Founder and Chief Growth Officer

Lori Challenger

Chief of Staff

Cybin Inc.

We’re on a mission to revolutionize mental healthcare. Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

We are focused on addressing the mental health crisis and transforming the treatment landscape. To do that, we are combining technology and our scientific expertise to pair novel psychedelic molecules with controllable drug delivery systems, aimed at improving outcomes for patients.